to combat fraudulent activities and protect the public from further harm and loss.From left : (1) Budsara Trithipcharoenchai, Senior Executive Vice President of Capital Market Development Fund, (2
performance Strategic Allocation Policy Tactical Asset Allocation Policy Investment performance Strategic Allocation Policy Tactical Asset Allocation Policy Strategic Allocation Policy Security Selection P as
56-1 : Annual Registration Statements ( 2 record(s) found) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2022 31/03/2023 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2021 31
Mr. Vijchu Chantatub During 24 - 29 October 2018 and 13 November 2018, Mr. Vijchu Chantatub as a private fund manager, managed a private fund without honesty and care to preserve the interests of the
1 NO. NCH 024/2562 July 11, 2019 Subject : Notice of setting up a new subsidiary under joint venture agreement to cover intermediate care and wellness business Attn. : Director and Manager The Stock
) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2018 02/04/2019 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2017 30/03/2018 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2016 31
) Name Year Receive Date Details EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2020 02/04/2021 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2019 30/03/2020 EKACHAI MEDICAL CARE PUBLIC COMPANY LIMITED 2018 02
of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27 Notification of the resignation of Chairman of the Audit
alerts, and further enhances collaboration with the AOC to combat fraudulent schemes. SEC Secretary-General Pornanong Budsaratragoon said: “The SEC is fully aware of the urgent issue of fraudulent
Committee, Appointment of Audit Committee, Appointment of Company Secretary, the Establishment of New Subsidiary and Subsidiary to Purchase Drug Care Company Limited (Revise no. 2) 10/11/2021 09:27